2014—2023年济宁市食管癌发病和死亡趋势分析及2024—2030年预测
Trends of Esophageal Cancer Incidence and Mortality in Jining from 2014 to 2023 and Predictions from 2024 to 2030
投稿时间:2025-01-02  修订日期:2025-03-28
DOI:
中文关键词:  食管癌、发病率、死亡率、变化趋势、预测
英文关键词:esophageal cancer  incidence  mortality  trend  prediction
基金项目:基金项目:山东省医药卫生科技发展计划(202012051127);山东省医药卫生科技发展计划(202412051228);山东省医务职工科技创新计划(SDYWZGKCJHLH2023083);济宁市重点研发计划(2023YXNS173)
作者单位邮编
段雯华 济宁市疾控中心慢性病防制科 272000
王梅 济宁市疾病预防控制中心 272000
姜帆 山东省疾病预防控制中心 250012
李季 济宁市疾病预防控制中心 272000
李瑞 济宁市疾病预防控制中心 272000
王连顺 济宁市疾病预防控制中心 272000
付振涛 山东省疾病预防控制中心 272000
梁玉民* 济宁市疾病预防控制中心 272000
摘要点击次数: 60
全文下载次数: 0
中文摘要:
      摘要:目的 分析2014—2023年济宁市食管癌的发病率和死亡率变化趋势,并预测2024—2030年发展趋势。方法 2014—2023年济宁市食管癌发病和死亡数据来源于山东省肿瘤登记系统,按性别、年龄和城乡分层,分别计算不同年份的食管癌的粗发病(死亡)率、年龄别发病(死亡)率、中标发病(死亡)率等指标,标化率采用2000年中国标准人口和年龄构成。应用Joinpoint软件计算发病率和死亡率的平均年度变化百分比(AAPC)。应用GM(1,1)灰色模型预测2024—2030年食管癌的发病和死亡趋势。结果 2014—2023年济宁市食管癌标化发病率和标化死亡率均呈下降趋势,标化发病率从2014年的25.31/10万下降至2023年的12.75/10万(AAPC= -8.24%,P < 0.001),标化死亡率从2014年的12.84/10万下降至2023年的9.10/10万(AAPC= -5.91%,P < 0.001)。不同性别和城乡地区人群的标化发病率和标化死亡率也均呈下降趋势。男性发病和死亡水平均始终高于女性,农村地区发病和死亡水平均始终高于城市地区。40岁及以上各年龄组人群食管癌发病率均呈下降趋势,40~79岁各年龄组死亡率均呈下降趋势。从年龄分布来看,40岁以下年龄组食管癌的发病和死亡极少,绝大部分集中在60岁以上老年人中。GM(1,1)灰色模型预测结果显示,2024—2030年食管癌标化发病率和标化死亡率将进一步下降,预计2030年食管癌标化发病率和标化死亡率将分别下降至6.00/10万和4.90/10万。结论 2014—2023年济宁市食管癌发病率和死亡率总体呈持续下降趋势,预计至2030年将进一步降低。然而,当前疾病负担仍高于2022年全国水平,且男性、老年人和农村地区人群负担尤为突出。建议针对上述高危人群强化干预和筛查措施,以持续减轻食管癌疾病负担。
英文摘要:
      Abstract: Purpose To analyze the trend of incidence and mortality of esophageal cancer in Jining from 2014 to 2023 and predict the development trend from 2024 to 2030. Methods Data on incidence and mortality of esophageal cancer in Jining from 2014 to 2023 were derived from the Shandong cancer registration system. The crude incidence (mortality) rate, age-specific incidence (mortality) rate, and age- standardized incidence/mortality rates (ASIR/ASMR) of esophageal cancer in different years were calculated according to gender, age and urban and rural stratification. The standardized rate was based on the Chinese standard population in 2000. The average annual percentage change (AAPC) of incidence and mortality were calculated by Joinpoint software. The GM (1,1) grey model was used to predict the trend of esophageal cancer incidence and mortality from 2024 to 2030. Results From 2014 to 2023, The age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) of esophageal cancer in Jining showed a decreasing trend. The ASIR decreased from 25.31/100,000 to 12.75/100,000(AAPC= -8.24%, P < 0.001), and the ASMR decreased from 12.84/100,000 in 2014 to 9.10/ 100,000 in 2023 (AAPC= -5.91%, P < 0.001). The ASIR and ASMR of male, female, urban and rural population also showed a downward trend. The incidence and mortality rates of men were always higher than those of women, and incidence and mortality rates of rural areas were always higher than those of urban areas. The incidence of esophageal cancer in all age groups aged 40 and above showed a decreasing trend, and the mortality in all age groups aged 40-79 showed a decreasing trend. From the perspective of age distribution, the incidence and mortality rates of esophageal cancer are significantly lower among individuals under the age of 40, whereas the majority of cases are concentrated in the elderly population aged 60 and above. The GM (1,1) gray model predicted that the ASIR and ASMR of esophageal cancer would further decrease from 2024 to 2030, and it is expected that the ASIR and ASMR of esophageal cancer would decrease to 6.00/100,000 and 4.90/100,000 respectively in 2030. Conclusion From 2014 to 2023, the incidence and mortality of esophageal cancer in Jining showed a continuous downward trend, and it is expected to further decrease by 2030. However, the current burden of disease is still higher than the national level for 2022, and the burden is particularly high among men, the elderly and people in rural areas. It is recommended to strengthen intervention and screening measures for the above high-risk groups to continuously reduce the burden of esophageal cancer.
在线阅读     查看/发表评论  下载PDF阅读器